13 of the Top 20 Biopharmas Standardize Globally on Veeva Link Key People

Rhea-AI Summary

Veeva Systems (NYSE: VEEV) announced that 13 of the top 20 biopharmas have standardized globally on Veeva Link Key People to enhance customer engagement and supply structured datasets for AI. The product added 38 new customers, and 3 top-20 biopharmas became global standards in the past year.

Link Key People is part of Veeva Data Cloud and uses Veeva's Common Data Architecture to connect Link with OpenData, HCP 360, Compass, AI-powered summaries, personalized notifications, and a high-speed Link Direct Data API for analytics and model feeding.

Positive

• 13 of top 20 biopharmas standardized on Link Key People globally
• 38 new customers added across biopharma and emerging biotech
• 3 top-20 biopharmas adopted Link Key People as global standard within one year
• Link Direct Data API provides high-speed programmatic access for analytics and AI

Negative

• None.

News Market Reaction – VEEV

-0.06%

1 alert

-0.06% News Effect

On the day this news was published, VEEV declined 0.06%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Top biopharmas standardized: 13 of top 20 biopharmas New Link customers: 38 new customers New top-20 standards: 3 top-20 biopharmas

3 metrics

Top biopharmas standardized 13 of top 20 biopharmas Have standardized globally on Veeva Link Key People

New Link customers 38 new customers Biopharmas of all sizes added within the last year

New top-20 standards 3 top-20 biopharmas Made Link Key People their global standard in the last year

Market Reality Check

Price: $176.46 Vol: Volume 4,590,334 is 2.25x...

high vol

$176.46 Last Close

Volume Volume 4,590,334 is 2.25x the 20-day average of 2,038,598, indicating elevated trading activity ahead of/around this news. high

Technical Shares at $190.80 are trading 38.55% below the 52-week high of $310.50 and just 2.36% above the 52-week low of $186.40, and are below the 200-day MA of $263.08.

Peers on Argus

While VEEV is down 6.17%, several health information peers are also negative: DO...

While VEEV is down 6.17%, several health information peers are also negative: DOCS -5.79%, TEM -5.52%, WAY -6.42%, and HQY -5.09%, with GEHC -1.06%. This indicates broader sector pressure, though the scanner did not flag a coordinated momentum move.

Historical Context

5 past events · Latest: Jan 29 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 29	Product launch (eSource)	Positive	-3.7%	Announced Veeva eSource to eliminate paper and streamline clinical data flow.
Jan 27	AI industry report	Neutral	-2.8%	Highlighted State of AI in Consumer Goods report and AI-readiness priorities.
Jan 08	Conference appearance	Neutral	-0.4%	Planned presentation at J.P. Morgan 2026 Healthcare Conference with webcast.
Jan 08	Strategic partnership	Positive	+0.8%	Long-term enterprise agreement with BioMarin to expand Veeva collaboration.
Jan 08	Product launch (quality)	Positive	+0.8%	Announced Veeva Environmental Monitoring to modernize QC manufacturing workflows.

Pattern Detected

Recent product and partnership announcements have often seen mixed to negative next-day price reactions, with only some launches and partnerships aligning positively with share moves.

Recent Company History

Over the past month, Veeva has issued several product and partnership updates. On Jan 8, 2026, it announced Veeva Environmental Monitoring and a long-term strategic partnership with BioMarin, each followed by a +0.76% move. A J.P. Morgan conference appearance the same day saw a modest -0.43% reaction. Later, AI-focused and clinical-data announcements on Jan 27 and Jan 29 corresponded with declines of -2.81% and -3.67%. Today’s positive customer-adoption news fits this pattern of constructive updates amid share price weakness.

Market Pulse Summary

This announcement underscores expanding adoption of Veeva Link Key People, with 13 of the top 20 bio...

Analysis

This announcement underscores expanding adoption of Veeva Link Key People, with 13 of the top 20 biopharmas standardized globally and 38 new customers added over the last year. It reinforces Veeva’s role in supplying structured data for AI initiatives and HCP engagement across medical and commercial teams. In context of recent launches and partnerships, investors may watch how this traction contributes to broader platform usage, data-cloud growth, and future disclosures on financial impact and customer retention.

Key Terms

ai, hcp, api, kol, +2 more

6 terms

ai technical

"trust Link to power customer engagement and provide structured datasets to fuel AI initiatives"

Artificial intelligence (AI) is technology that enables machines to mimic human thinking and learning, allowing them to analyze information, recognize patterns, and make decisions. For investors, AI matters because it can improve how businesses operate, create new products, or identify opportunities faster and more accurately than humans alone, potentially impacting company success and market trends.

hcp medical

"more engaging HCP interactions — altogether benefiting patient healthcare"

An HCP (healthcare professional) is a licensed medical practitioner—such as a doctor, nurse, pharmacist or clinician—who diagnoses, treats and advises patients. For investors, HCPs are important because their prescribing choices and treatment recommendations directly affect product sales and market uptake, acting like gatekeepers whose preferences and acceptance can determine a therapy’s commercial success and regulatory exposure.

api technical

"Additionally, the Link Direct Data API gives data teams access"

An API, or Application Programming Interface, is a set of rules that allows different software programs to communicate and work together smoothly, much like a waiter translating your order into the kitchen and then bringing your meal back. For investors, APIs are important because they enable real-time access to financial data, trading systems, and other digital services, making it easier to make informed decisions quickly and efficiently.

kol medical

"advance engagement across the industry with deep KOL data for strategic"

A KOL, or key opinion leader, is a trusted expert—often a leading physician, researcher, or specialist—whose views influence peers, clinical practice, and industry adoption of medical products or treatments. For investors, KOL endorsements or criticisms can sway adoption rates, regulatory perceptions, and market confidence much like a respected critic can affect demand for a new product, so monitoring KOL sentiment helps gauge commercial and clinical prospects.

data cloud technical

"Link Key People is part of Veeva Data Cloud, which includes"

A data cloud is a network of remote computers and storage that companies rent to hold, process and analyze their information instead of keeping it on their own machines. Think of it as leasing a flexible, staffed warehouse for digital files and computing work. Investors watch data cloud use because it can lower costs, speed product development, enable new services, and concentrate business risk in providers whose performance, pricing, and security affect profits and growth.

common data architecture technical

"Link Key People uses Veeva's Common Data Architecture (CDA) to connect data"

A common data architecture is a standardized blueprint for how an organization collects, stores and shares information so different teams and software can understand and use the same data consistently. For investors it matters because it reduces costly confusion and delays—like using uniform parts when building a machine—leading to faster analysis, clearer financial reporting, lower operational risk, and quicker product or service improvements that can affect revenue and valuation.

AI-generated analysis. Not financial advice.

Emerging biotechs and top biopharmas trust Link to power customer engagement and provide structured datasets to fuel AI initiatives

PLEASANTON, Calif., Feb. 4, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that 13 of the top 20 biopharmas have standardized on Veeva Link Key People to enhance customer engagement and provide data for AI globally. Biopharmas of all sizes use Link Key People, with 38 new customers added and three of the top 20 biopharmas making it their global standard within the last year.

"Access to Veeva Link Key People further strengthens data-driven decision-making, enhances laser-sharp targeting, and fosters more engaging HCP interactions — altogether benefiting patient healthcare. As ingested, Link Key People data has become an organic part of Bayer's Data DNA, it enriches the outputs of our agentic, AI-driven platforms, delivering more relevant and actionable business insights for the long-term benefit of patients," said Dr. Daniel Jardanhazi-Kurutz, deputy director for customer engagement at Bayer AG.

Link Key People delivers value to medical and commercial teams by providing trusted insights, while analytics teams can use Link data to feed their AI models. Recent innovations, such as AI-powered summaries, personalized notifications, and new digital data sources, further improve customer interactions and help to uncover new engagement opportunities. Additionally, the Link Direct Data API gives data teams access to Veeva's new class of API that provides high-speed access to data.

"Trusted customer insights are the foundation for AI advancement and help achieve launch performance. With more top biopharmas and emerging biotechs using Link Key People, we will continue to learn and advance engagement across the industry with deep KOL data for strategic and impactful relationships," said David Medina Tato, vice president of strategy for Link Key People at Veeva.

Link Key People is part of Veeva Data Cloud, which includes Veeva OpenData, Veeva HCP 360, and Veeva Compass, and Link Key People uses Veeva's Common Data Architecture (CDA) to connect data and software.

About Veeva Systems
Veeva delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Veeva Forward-Looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2025, which you can find here (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov.

Contact:
Alison Borris
Veeva Systems
alison.borris@veeva.com|

View original content to download multimedia:https://www.prnewswire.com/news-releases/13-of-the-top-20-biopharmas-standardize-globally-on-veeva-link-key-people-302678526.html

SOURCE Veeva Systems

FAQ

Which biopharmas standardized on Veeva Link Key People as of February 4, 2026 (VEEV)?

Direct answer: 13 of the top 20 biopharmas standardized on Link Key People globally. According to Veeva, three of those top-20 companies made Link Key People their global standard within the last year, and 38 new customers were added overall.

How does Veeva Link Key People (VEEV) support AI initiatives for biopharma companies?

Direct answer: Link Key People supplies structured datasets and high-speed API access to feed AI models and analytics. According to Veeva, features include AI-powered summaries, personalized notifications, and the Link Direct Data API to accelerate model training and insights.

What components of Veeva Data Cloud integrate with Link Key People for VEEV customers?

Direct answer: Link Key People integrates with Veeva OpenData, Veeva HCP 360, and Veeva Compass under Veeva Data Cloud. According to Veeva, it uses the Common Data Architecture to connect datasets and software for unified analytics and engagement workflows.

What tangible adoption metrics did Veeva announce for Link Key People on February 4, 2026 (VEEV)?

Direct answer: Veeva reported 13 of the top 20 biopharmas standardizing on Link Key People and 38 new customers added. According to Veeva, three top-20 biopharmas adopted it as their global standard within the past year.

How might Link Key People improve commercial and medical engagement for VEEV customers?

Direct answer: Link Key People aims to provide trusted insights to improve targeting, engagement, and launch performance. According to Veeva, medical and commercial teams use the data for sharper HCP interactions while analytics teams feed the data into AI models for actionable insights.